CMS Open Payments · Program Year 2024
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP reported $428,167,709.31 in payments to 858,609 physicians and teaching hospitals across 864,383 transactions.
- $428.2M
- Total payments
- 864,383
- Transactions
- 858,609
- Recipients
- +$7.5M
- General Payments vs PY2023
AstraZeneca Pharmaceuticals LP reported $428,167,709.31 in payments to 858,609 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #7 of 1,925 reporting manufacturers (3.1% of all US industry payments), averaging $498.68 per recipient across 11 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
AstraZeneca Pharmaceuticals LP pairs top-1% payment volume with an unusually diversified payment pattern across a wide recipient base.
- #7
- of 1,925 companies
- 3.1%
- of all US industry payments
- 0.0%
- paid to its single top recipient
- 11
- payment categories
Release-over-release change
General Payments changed from PY2023 to PY2024
AstraZeneca Pharmaceuticals LP's CMS-reported General Payments increased by $7.5M (+13.1%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.
CMS source labels for this exact identifier: PY2022: ASTRAZENECA PHARMACEUTICALS LPPY2023: ASTRAZENECA PHARMACEUTICALS LPPY2024: AstraZeneca Pharmaceuticals LP. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $57,247,929.30
- PY2024
- $64,724,186.83
How AstraZeneca Pharmaceuticals LP ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
AstraZeneca Pharmaceuticals LP's total vs. every reporting company
CMS Open Payments, Program Year 2024
$428,167,709 Top 1% higher than 99% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for AstraZeneca Pharmaceuticals LP
Rank #7 of 1,925 companies in CMS Open Payments for 2024 belongs to AstraZeneca Pharmaceuticals LP, which reported $428,167,709.31 across 864,383 transactions to 858,609 recipients - a top-tier 3.1% share of all industry payments reported nationwide for the year. Averages work out to $495.34 per transaction and $498.68 per recipient.
The 11-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $28.4M, accounting for 6.6% of the company's reported total and 12,785 transactions.
General Payment Breakdown by Type
AstraZeneca Pharmaceuticals LP made 11 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $28.4M, 6.6% of the company's reported total.
How AstraZeneca Pharmaceuticals LP divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $28.4M | 12,785 | 6.6% |
| Food and Beverage | $17.4M | 824,499 | 4.1% |
| Consulting Fee | $9.5M | 4,937 | 2.2% |
| Grant | $4.3M | 220 | 1.0% |
| Travel and Lodging | $3.3M | 10,541 | 0.8% |
| Space Rental or Facility Fees | $1.4M | 615 | 0.3% |
| Gift | $187.0K | 11 | 0.0% |
| Education | $113.3K | 4,747 | 0.0% |
| Royalty or License | $92.5K | 1 | 0.0% |
| Compensation for Faculty or Speaker (Medical Education) | $56.0K | 130 | 0.0% |
| Charitable Contribution | $38.1K | 123 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $3,731,100.52 (5.8%) of $64,724,186.83 in this company's General Payments records across 138,305 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for AstraZeneca Pharmaceuticals LP
The five named recipients with the highest reported General Payments from this company
- 1
National Jewish Health
$2,428,146.00 across 18 reported transactions
- 2
Howard University Hospital
$387,650.00 across 4 reported transactions
- 3
Ohsu Hospital And Clinics
$376,360.00 across 7 reported transactions
- 4
Emory University Hospital
$278,944.52 across 14 reported transactions
- 5
Tufts Medical Center
$260,000.00 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Payment Size Analysis
Average transaction size: $495.34. Average per recipient: $498.68.
Total Amount
$428,167,709.31
Avg per Transaction
$495.34
Avg per Recipient
$498.68
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
AstraZeneca Pharmaceuticals LP Share
3.1%
#7 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to AstraZeneca Pharmaceuticals LP
Frequently Asked Questions
How much did AstraZeneca Pharmaceuticals LP pay to physicians and hospitals in 2024? ▾
How many physicians received payments from AstraZeneca Pharmaceuticals LP? ▾
What types of payments did AstraZeneca Pharmaceuticals LP make? ▾
How does AstraZeneca Pharmaceuticals LP rank among pharmaceutical companies? ▾
What is the average payment size from AstraZeneca Pharmaceuticals LP? ▾
Where does the payment data for AstraZeneca Pharmaceuticals LP come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.